{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Tiazofurin",
  "nciThesaurus": {
    "casRegistry": "60084-10-8",
    "chebiId": "",
    "chemicalFormula": "C9H12N2O5S",
    "definition": "A synthetic nucleoside analogue with antineoplastic activity. Tiazofurin (TR) is anabolized intracellularly to an analogue of NAD, tiazole-4-carboxamide adenine dinucleotide (TAD), a potent inhibitor of IMP dehydrogenase (IMPDH); IMPDH is the rate-limiting enzyme for de novo purine synthesis. Inhibition of IMPDH results in reduced levels of guanylates, resulting in the inhibition tumor cell growth in vitro and in vivo.",
    "fdaUniiCode": "ULJ82834RE",
    "identifier": "C1254",
    "preferredName": "Tiazofurin",
    "semanticType": "Organic Chemical",
    "subclassOf": [],
    "synonyms": [
      "2-.beta.-D-Ribofuranosyl-4-thiazolecarboxamide",
      "2-.beta.-D-Ribofuranosylthiazole-4-carboxamide",
      "2-Beta-D-ribofuranosyl-4-thiazolecarboxamide",
      "2-Beta-D-ribofuranosylthiazole-4-carboxamide",
      "4-Thiazolecarboxamide, 2-.beta.-D-ribofuranosyl- (9CI)",
      "4-Thiazolecarboxamide, 2-Beta-D-ribofuranosyl- (9CI)",
      "Riboxamide",
      "TCAR",
      "TIAZOFURIN",
      "Tiazofurin",
      "Tiazofurine",
      "tiazofurin"
    ]
  }
}